Overview
CH50 measures the ability of patient serum to lyse antibody-sensitized sheep erythrocytes via the classical complement pathway.
Clinical Importance
Screen for classical pathway complement component deficiencies
Assess complement consumption in selected immune-complex diseases
Specimen Requirements
- Specimen: serum (preferred for most serology/autoimmune immunoassays) or plasma when the method is validated
- Tube: gold/SST (serum separator) or red-top serum; follow method-specific plasma acceptability
- Handling: allow SST to clot fully; centrifuge and separate promptly; avoid repeated freeze–thaw
- Storage: refrigerate short-term; freeze aliquots for delayed testing per manufacturer stability
- Stability: analyte- and kit-specific; do not exceed validated time/temperature limits
- Complement is labile; freeze promptly if testing is delayed per SOP
Analytical Method
Serial dilutions of serum are incubated with sensitized erythrocytes; the dilution producing 50% hemolysis defines CH50. Liposomal and immunoassay alternatives exist on some platforms.
Instruments Used
Automated analyzers
- Roche Cobas immunoassay systems
- Abbott Alinity / Architect immunoassay systems
- Siemens Healthineers Atellica / ADVIA Centaur immunoassay systems
- Beckman Coulter Access / DxI immunoassay systems
- bioMérieux VIDAS / BioFire immunoassays (selected analytes)
- Ortho Clinical Diagnostics Vitros immunoassay systems
- DiaSorin LIAISON immunoassay systems
- Phadia / Thermo Fisher ImmunoCAP allergy systems
- Manual ELISA, CLIA, and immunofluorescence platforms
Manual methods
- Manual ELISA, agglutination, and immunofluorescence methods in selected settings
Reference Values
Assay cutoffs, units, and reference intervals are method- and manufacturer-specific. Always interpret against the performing laboratory report (CLSI EP28-A3c for quantitative intervals where applicable). Serologic patterns require clinical correlation and current guideline algorithms (WHO/CDC/society guidance as adopted locally).
Method-specific units (U/mL or % of normal). Use the laboratory’s interval; values are not interchangeable across methods.
Interpretation
Common Causes of Increased Results
- Elevated CH50 may occur in acute-phase states; clinical correlation required
Common Causes of Decreased Results
- Low CH50; complement consumption or inherited/acquired component deficiency; follow with C3/C4 and individual components as indicated
Clinical Significance
- Complement deficiency evaluation
- Selected SLE and immune-complex disease monitoring adjuncts
Factors Affecting Results
Pre-analytical
- Delayed processing or improper storage destroying complement activity (false low)
- Repeated freeze–thaw
Analytical
- Calibration/QC failure; reagent lot shifts
- Hook effect / antigen excess on selected immunoassays
- Heterophile antibodies, rheumatoid factor, or biotin interference (assay-dependent)
Post-analytical
- Applying another laboratory’s cutoff to a different method
- Interpreting a single serology result without clinical timing and confirmatory algorithms
Advantages and Limitations
Advantages
- Functional screen of classical pathway
Limitations
- Does not localize the missing component alone
- Highly preanalytically sensitive
Clinical Pearls
A low CH50 on a sample that sat warm on the bench is often ruined complement; not a new immunodeficiency.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods (verify current edition). Chapters on clinical immunology and serology.
- Rifai N, Horvath AR, Wittwer CT, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (verify current edition). Immunoassay and protein chapters.
CLSI and Professional Guidelines
- Centers for Disease Control and Prevention. Laboratory testing recommendations for infectious disease serology and related algorithms (verify current CDC guidance for the pathogen).
- Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory. CLSI document EP28-A3c (verify current edition).
- Clinical and Laboratory Standards Institute. Immunoassay and related method evaluation documents (e.g., EP05, EP06, EP07, EP17; verify current editions relevant to the assay).
- College of American Pathologists. Accreditation and proficiency testing expectations for immunology/serology (verify current CAP checklist requirements).
- International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Recommendations relevant to protein and immunoassay measurands (verify current IFCC documents).
WHO Publications
- World Health Organization. Laboratory and diagnostic guidance for serologic and immunologic testing (verify current WHO publication for the analyte/assay).
Frequently Asked Questions
Common questions about using this CH50 (Total Complement Activity) laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the CH50 (Total Complement Activity) laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of CH50 (Total Complement Activity). Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find CH50 (Total Complement Activity) specimen requirements?
See the Specimen Requirements section on this page for specimen information related to CH50 (Total Complement Activity). Confirm collection details against your laboratory protocol.
Where are CH50 (Total Complement Activity) reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret CH50 (Total Complement Activity) results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for CH50 (Total Complement Activity)?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from CH50 (Total Complement Activity)?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading CH50 (Total Complement Activity)?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Immunology & Serology topic.
What are the clinical pearls for CH50 (Total Complement Activity)?
See the Clinical Pearls section for concise laboratory practice notes associated with CH50 (Total Complement Activity). Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.